Literature DB >> 11447834

Dysfunctional intracellular calcium homoeostasis: a central cause of neurodegeneration in Alzheimer's disease.

C O'Neill1, R F Cowburn, W L Bonkale, T G Ohm, J Fastbom, M Carmody, M Kelliher.   

Abstract

The clinical symptoms of all forms of Alzheimer's disease (AD) result from a slowly progressive neurodegeneration that is associated with the excessive deposition of beta-amyloid (A beta) in plaques and in the cerebrovasculature, and the formation of intraneuronal neurofibrillary tangles, which are composed primarily of abnormally hyperphosphorylated tau protein. The sequence of cellular events that cause this pathology and neurodegeneration is unknown. It is, however, most probably linked to neuronal signal transduction systems that become misregulated in the brains of certain individuals, causing excessive A beta to be formed and/or deposited, tau to become aggregated and hyperphosphorylated and neurons to degenerate. We hypothesize that a progressive alteration in the ability of neurons to regulate intracellular calcium, particularly at the level of the endoplasmic reticulum, is a crucial signal transduction event that is linked strongly to the initiation and development of AD pathology. In this chapter we will discuss the key findings that lend support to this hypothesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11447834     DOI: 10.1042/bss0670177

Source DB:  PubMed          Journal:  Biochem Soc Symp        ISSN: 0067-8694


  13 in total

1.  Novel mechanism of increased Ca2+ release following oxidative stress in neuronal cells involves type 2 inositol-1,4,5-trisphosphate receptors.

Authors:  S Kaja; R S Duncan; S Longoria; J D Hilgenberg; A J Payne; N M Desai; R A Parikh; S L Burroughs; E V Gregg; D L Goad; P Koulen
Journal:  Neuroscience       Date:  2010-11-11       Impact factor: 3.590

2.  Verapamil prevents, in a dose-dependent way, the loss of ChAT-immunoreactive neurons in the cerebral cortex following lesions of the rat nucleus basalis magnocellularis.

Authors:  Miroljub Popović; Maria Caballero-Bleda; Natalija Popović; Luis Puelles; Thomas van Groen; Menno P Witter
Journal:  Exp Brain Res       Date:  2005-11-23       Impact factor: 1.972

Review 3.  Antihypertensive agents for aging patients who are at risk for cognitive dysfunction.

Authors:  Ihab Hajjar; Michelle Keown; Brandy Frost
Journal:  Curr Hypertens Rep       Date:  2005-12       Impact factor: 5.369

4.  NMDA-mediated Ca(2+) influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer's disease mice.

Authors:  Ivan Goussakov; Megan B Miller; Grace E Stutzmann
Journal:  J Neurosci       Date:  2010-09-08       Impact factor: 6.167

5.  Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's disease.

Authors:  Takahide Kaji; Barry Boland; Tatjana Odrljin; Panaiyur Mohan; Balapal S Basavarajappa; Corrinne Peterhoff; Anne Cataldo; Anna Rudnicki; Niranjana Amin; Bing Sheng Li; Harish C Pant; Basalingappa L Hungund; Ottavio Arancio; Ralph A Nixon
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

6.  Age-related toxicity of amyloid-beta associated with increased pERK and pCREB in primary hippocampal neurons: reversal by blueberry extract.

Authors:  Gregory J Brewer; John R Torricelli; Amanda L Lindsey; Elizabeth Z Kunz; A Neuman; Derek R Fisher; James A Joseph
Journal:  J Nutr Biochem       Date:  2009-12-01       Impact factor: 6.048

Review 7.  Hypertension and dementia.

Authors:  Olivier Hanon; Marie Laure Seux; Hermine Lenoir; Anne Sophie Rigaud; Françoise Forette
Journal:  Curr Cardiol Rep       Date:  2003-11       Impact factor: 2.931

Review 8.  Prevention of dementia and cerebroprotection with antihypertensive drugs.

Authors:  Olivier Hanon; Marie Laure Seux; Hermine Lenoir; Anne Sophie Rigaud; Françoise Forette
Journal:  Curr Hypertens Rep       Date:  2004-06       Impact factor: 5.369

Review 9.  Ageing and neuronal vulnerability.

Authors:  Mark P Mattson; Tim Magnus
Journal:  Nat Rev Neurosci       Date:  2006-04       Impact factor: 34.870

10.  Interactions between the amyloid precursor protein C-terminal domain and G proteins mediate calcium dysregulation and amyloid beta toxicity in Alzheimer's disease.

Authors:  Gideon M Shaked; Stephanie Chauv; Kiren Ubhi; Lawrence A Hansen; Eliezer Masliah
Journal:  FEBS J       Date:  2009-04-02       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.